Skip to content

Multi-center follow-up study of MG7 and MG5 combined screening for early warning of gastric cancer risk

Multi-center follow-up study of MG7 and MG5 combined screening for early warning of gastric cancer risk

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074264
Enrollment
Unknown
Registered
2023-08-02
Start date
2023-08-03
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Diseases

Interventions

High Risk group:Low grade intraepithelial neoplasia, High grade intraepithelial neoplasia
Low Risk group:Chronic atrophic gastritis, Intestinal metaplasia of gastric mucosa

Sponsors

National Clinical Research Center for Digestive Diseases/The First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age =40 years old, gender unlimited; 2) Pre-gastric cancer diseases with definite pathological diagnosis, including superficial gastritis, atrophic gastritis (with intestinal metaplasia), low-grade intraepithelial neoplasia at any time, and adenoma. 3) White tablets can be prepared with wax blocks of previous pathological diagnosis tissue, and immunohistochemical staining can be carried out.

Exclusion criteria

Exclusion criteria: 1) Gastric precancerous lesions accompanied by canceration, gastric precancerous lesions accompanied by other malignant tumors, and patients with a history of malignant tumors; 2) severe diseases of heart, lung, liver and kidney function. Exclusion criteria: 1) people who developed other serious diseases (other malignant tumors or severe heart, lung, liver and kidney function) during follow-up: 2 Population lost to follow-up early in the study 3) cases dropped off during the study period due to other populations

Design outcomes

Primary

MeasureTime frame
Pathological immunohistochemical results;OR;AR;

Countries

China

Contacts

Public ContactZhe Wang

The First Affiliated Hospital of Air Force Military Medical University

kaicwu@fmmu.edu.cn+86 137 0921 8743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026